Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer

Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer

In recent years, Non-small cell lung cancer (NSCLC) has evolved into a prime example for precision oncology with multiple FDA-approved “precision” drugs. For the majority of NSCLC lacking targetable genetic alterations, immune checkpoint inhibition (ICI) has become standard of care in first-line tre...

Full description

Bibliographic Details
Main Authors: Stefanie Schatz, Markus Falk, Balázs Jóri, Hayat O. Ramdani, Stefanie Schmidt, Eva-Maria Willing, Roopika Menon, Harry J. M. Groen, Linda Diehl, Matthias Kröger, Claas Wesseler, Frank Griesinger, Petra Hoffknecht, Markus Tiemann, Lukas C. Heukamp
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
immuno-oncology
tumor mutational burden
lung cancer
routine diagnostics
driver mutation
PD-L1
Online Access:https://www.mdpi.com/2072-6694/12/6/1685

Internet

https://www.mdpi.com/2072-6694/12/6/1685

Similar Items